BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 18999921)

  • 1. Are we approaching the post-blockbuster era? Pharmacodiagnostics and rational drug development.
    Jørgensen JT
    Expert Rev Mol Diagn; 2008 Nov; 8(6):689-95. PubMed ID: 18999921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-directed combinatorial library design.
    Zhou JZ
    Curr Opin Chem Biol; 2008 Jun; 12(3):379-85. PubMed ID: 18328830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personalized medicine: elusive dream or imminent reality?
    Lesko LJ
    Clin Pharmacol Ther; 2007 Jun; 81(6):807-16. PubMed ID: 17505496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From blockbuster medicine to personalized medicine.
    Jørgensen JT
    Per Med; 2008 Jan; 5(1):55-63. PubMed ID: 29783394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenge of personalized health care: to what extent is medicine already individualized and what are the future trends?
    Fierz W
    Med Sci Monit; 2004 May; 10(5):RA111-23. PubMed ID: 15114285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The integration of molecular diagnostics with therapeutics. Implications for drug development and pathology practice.
    Ross JS; Ginsburg GS
    Am J Clin Pathol; 2003 Jan; 119(1):26-36. PubMed ID: 12520694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of pharmacogenomics for drug development.
    Kirk RJ; Hung JL; Horner SR; Perez JT
    Exp Biol Med (Maywood); 2008 Dec; 233(12):1484-97. PubMed ID: 18849536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges of drug discovery for personalized medicine.
    Jain KK
    Curr Opin Mol Ther; 2006 Dec; 8(6):487-92. PubMed ID: 17243483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating post-marketing exposure to pharmaceutical products using ex-factory distribution data.
    Telfair T; Mohan AK; Shahani S; Klincewicz S; Atsma WJ; Thomas A; Fife D
    Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):749-53. PubMed ID: 16758501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using disease progression models as a tool to detect drug effect.
    Mould DR; Denman NG; Duffull S
    Clin Pharmacol Ther; 2007 Jul; 82(1):81-6. PubMed ID: 17507925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current pharmacogenomic approaches to clinical drug development.
    Murphy MP
    Pharmacogenomics; 2000 May; 1(2):115-23. PubMed ID: 11256585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epiphany of data warehousing technologies in the pharmaceutical industry.
    Barrett JS; Koprowski SP
    Int J Clin Pharmacol Ther; 2002 Mar; 40(3):S3-13. PubMed ID: 11911607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Globalization of quantitative pharmacology: first international symposium of quantitative pharmacology in drug development and regulation.
    Barrett JS; Shi J; Xie HT; Huang XH; Fossler MJ; Sun RY
    J Clin Pharmacol; 2008 Jul; 48(7):787-92. PubMed ID: 18490494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of combinatorial chemistry and structure-based drug design.
    Antel J
    Curr Opin Drug Discov Devel; 1999 May; 2(3):224-33. PubMed ID: 19649950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hybrid molecules with a dual mode of action: dream or reality?
    Meunier B
    Acc Chem Res; 2008 Jan; 41(1):69-77. PubMed ID: 17665872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacology considerations in development of gastrohepatology products.
    Lee SC; Apparaju S; Kim I; Estes K; Jappar D; Bashaw ED
    Clin Pharmacol Ther; 2012 Sep; 92(3):281-3. PubMed ID: 22910484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward theragnostics.
    Pene F; Courtine E; Cariou A; Mira JP
    Crit Care Med; 2009 Jan; 37(1 Suppl):S50-8. PubMed ID: 19104225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular imaging to biomarker development in neuroscience.
    Frost JJ
    Ann N Y Acad Sci; 2008 Nov; 1144():251-5. PubMed ID: 19076382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New methods in pharmaceutical research: combinatorial chemistry and high throughput screening].
    Schirlin D; Galvan M; Le Fur G
    Bull Acad Natl Med; 2007; 191(4-5):727-36; discussion 736-7. PubMed ID: 18225426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic advantage of pharmacogenomics - clinical trials with genetic information.
    Ohashi W; Mizushima H; Tanaka H
    Stud Health Technol Inform; 2008; 136():585-90. PubMed ID: 18487794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.